Table 1 Baseline characteristics and parameters between two groups
Sevelamer (n = 23) | Calcium Carbonate (n = 27) | P | |
|---|---|---|---|
Age (yr) | 59.61 ± 8.16 | 56.96 ± 7.72 | 0.248 |
Gender (male) | 11 (47.83 %) | 18 (66.67 %) | 0.149 |
Hemodialysis (yr) | 7.00 (5) | 5.00 (4) | 0.313 |
DM (no) | 9 (39.13 %) | 8 (29.63 %) | 0.557 |
Use of vitamin D (no) | 9 (39.13 %) | 13 (48.14 %) | 0.577 |
Use of vitamin D (months) | 77 | 81 | 0.775 |
LCB (no) | 7 (30.43 %) | 6 (22.22 %) | 0.537 |
Statin (no) | 7 (30.43 %) | 5 (18.52 %) | 0.305 |
Anti-hypertension drug (no) | 16 (69.56 %) | 20 (74.07 %) | 0.761 |
Ca (mg/dL) | 9.37 ± 0.66 | 9.37 ± 0.73 | 0.986 |
P (mg/dL) | 6.54 ± 0.91 | 7.22 ± 0.98 | 0.015* |
iPTH (pg/mL) | 354.70 (332.70) | 320.90 (371.8) | 0.633 |
ALK-P (IU/L) | 82.17 ± 32.71 | 65.67 ± 23.70 | 0.061 |
HsCRP (mg/L) | 2.3 (5.8) | 3.10 (6.1) | 0.697 |
Hct (%) | 33.10 ± 3.87 | 32.49 ± 3.11 | 0.549 |
Albumin (g/L) | 39.92 ± 3.13 | 39.81 ± 2.86 | 0.866 |
TG (mg/dL) | 98.00 (86.00) | 113.00 (127.00) | 0.459 |
LDL-C (mg/dL) | 108.96 ± 30.10 | 112.93 ± 33.46 | 0.661 |
Fetuin-A (ug/mL) | 210.61 (104.73) | 203.95 (107.87) | 0.961 |